John Oliver has some unhealthy information for Fox Information

HBO’s John Oliver has had to explain the difference between the films and real life to some of the figures outraged by East Palestine Fox News.

Video:

https://www.youtube.com/watch?v=qEDbc3RuM1I

Oliver said: “East Palestine, Ohio was visited by Donald Trump and Pete Buttigieg, but some Fox News figures insisted that others really should have been there too.”

John Oliver then played a clip of Jesse Watters and Rachel Campos-Duffy, with Duffy saying, “Think of the environmentalists and the American corporations, they weren’t there. This is an Erin Brockovich moment. I mean, there was a blockbuster, Oscar-winning film that was written about something like that.

Watters said, “Erin Brockovich is actually in East Palestine tonight.”

Subscribe to our newsletter:

Campos-Duffy said: “She is, but where is Julia Roberts?”

John Oliver, “What? What are you talking about? You do realize that Julia Roberts is an actress, right? She pretended. She’s not really Erin Brockovich. Also, I can’t believe I’m the one who has to tell you this. She didn’t really ruin her best friend’s wedding. She’s not a sex worker and she didn’t die in 1989 in a small Louisiana town. What the hell is wrong with you?”

Fox News’ efforts to politicize the East Palestine train derailment were bound to descend into the absurd, but nobody thought Fox News would slam Julia Roberts for not being there for the people of East Palestine. What’s next? Will Fox be outraged that Tom Cruise didn’t do some Mission Impossible stuff and keep the train from derailing?

John Oliver skewered how far Fox News went to make an environmental disaster a deeply partisan issue. Fox is so aloof and so unconcerned with reality that they are willing to take offense at Julia Roberts not showing up in East Palestine.

Jason is the managing editor. He is also a White House press pool and congressional correspondent for PoliticusUSA. Jason has a bachelor’s degree in political science. His thesis focused on public policy with a specialization in social reform movements.

Awards and professional memberships

Member of the Society of Professional Journalists and the American Political Science Association

CDC advisors advocate a vaccine for susceptible adults in future outbreaks

Vials of the JYNNEOS Monkeypox vaccine are prepared at a pop-up vaccination clinic in Los Angeles, California on August 9, 2022.

Patrick T Fallon | AFP | Getty Images

Independent advisors to the Centers for Disease Control and Prevention on Wednesday unanimously recommended giving the two-dose Jynneos vaccine to adults at risk of Mpox in the event of future outbreaks following last year’s unprecedented epidemic.

The US started using the Jynneos vaccine, which is manufactured by the Danish company Bavarian Nordic, widely reported for the first time last summer after the Biden administration declared a public health emergency in response to the sudden domestic spread of mpox. The virus has historically been mostly confined to West and Central Africa, but has now spread to more than 100 countries.

“It is important to note that an MPOX outbreak is identified by health authorities and an individual case may be considered an MPOX outbreak at the discretion of health authorities,” said Dr. Pablo Sanchez, Head of the CDC Committee’s MPOX Working Group.

dr Agam Rao, a public health official, said the vaccine could be used in the future if mpox is introduced by a traveler or through imported animals, or if a community needs preventive vaccination due to the spread of the virus at a nearby location.

“Local health officials, state health officials, and the federal government can all determine what counts as an outbreak,” Rao said. “If there’s a single case from a traveler in the United States, that could do it.”

Advisors’ recommendation Wednesday was not specific to men who have sex with men, the community hardest hit by the current epidemic. Although mpox is currently spread primarily through sexual contact, it is unclear how the virus would be transmitted in a future outbreak and which communities could be hardest hit, Rao said.

CDC advisors will meet again in June to discuss the use of the Jynneos vaccine for children at risk of Mpox in future outbreaks. The US is currently offering the vaccine to adults and adolescents who are at risk from the current epidemic.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Studies found that two doses of the Jynneos vaccine were at least 66% effective in preventing MPox, although other research found that the vaccines were up to 83% effective. The effectiveness of a single dose ranged from 36% to 86%, depending on the study.

It’s still unclear how effective the vaccine is for people with weakened immune systems, which is crucial given that 53% of people with MPOX in the US who disclosed their HIV status were positive.

The CDC does not currently recommend vaccination for people who have recovered from MPox because they should develop immunity to their disease, Rao said. It’s unclear if people will eventually need a booster dose, although a study is being conducted in the Democratic Republic of the Congo to answer that question, Rao said.

Serious side effects from the vaccine were rare in adults, according to the CDC, and none were noted in children. Seven cases of myocarditis and pericarditis, forms of heart inflammation, have been reported. The CDC has not found an increased risk of heart inflammation after vaccination, but has not ruled it out either.

Since May 2022, more than 30,000 cases of MPOX have been confirmed in the US. About 8% of people who contracted the virus were hospitalized and 32 died.

New cases have fallen dramatically since the August peak due to a successful vaccination campaign and greater awareness of the precautions to be taken. Although the US lifted the public health emergency in January, Rao said the current outbreak is not over.

dr Jamie Loehr, owner of Cayuga Family Medicine in Ithaca, New York, said, “This is a common disease.”

“Even now at the lowest level, we still have two cases per week, which is more than in recent years per year,” said Löhr.

Mpox is generally not fatal for most people, although it is often extremely painful, with lesions forming on sensitive areas such as the genitals.

People with severely compromised immune systems, especially those with HIV, are at much higher risk of serious illness and even death. Scientists found the death rate for people with advanced HIV who contracted MPox was 15% in a study of 382 cases published Tuesday in The Lancet.

More than 1 million doses of Jynneos have been administered during the current outbreak. The Food and Drug Administration approved the Jynneos vaccine in 2019 to prevent smallpox and mpox, which are related viruses.

The World Health Organization last year changed the name of the virus, originally called monkeypox, to reduce stigma.

Join us for CNBC’s Healthy Returns on March 29, where we’re hosting a virtual gathering of healthcare CEOs, scientists, investors and innovators to reflect on the advances made today in reinventing the future of medicine. We also have an exclusive look at the best investment opportunities in biopharma, healthcare technology and managed care. Learn more and register today: http://bit.ly/3DUNbRo

Why Ke Huy Quan’s speech on the 2023 SAG Awards impressed everybody in every single place

“And now we’re here tonight celebrating James Hong, Michelle Yeoh, Stephanie Hasu, Hong Chau And Harry Shum Jr.“, he continued. “The landscape now looks so different than before. So thank you to everyone in this room and to everyone who has contributed to these changes.”

Nodding to his co-star Michelle, Ke remarked, “I’m so glad that when we both started our careers in 1984, we would one day meet on the big screen.”

He concluded his speech with a special message to viewers: “To everyone watching at home, fighting and waiting to be seen, please keep going because the spotlight will find you one day.”

“Thanks for everyone rooting for me,” Ke added, “I will root for you.”

Hybrid work harms metropolitan eating places, bars: research

Commuters arrive at the Oculus station and mall in Manhattan on November 17, 2022 in New York City.

Spencer Platt | Getty Images

Sales are returning to pre-pandemic levels at many downtown restaurants and hotels — but only on Tuesdays, Wednesdays and Thursdays.

In cities like New York, Los Angeles, and Atlanta, the three-day in-person work week has presented challenges to the hospitality industry. With fewer employees in offices on Mondays and Fridays — the busiest days for some businesses — many businesses have been forced to stagger their hours or launch initiatives to attract customers at the beginning and end of the week.

Amali, a restaurant on the outskirts of Midtown Manhattan, pulls in just a quarter of its weekday business on Mondays and Fridays, said managing partner James Mallios.

Hotels are also seeing slower week starts and ends for business travelers. However, hotels across California have seen more instances of combined business and leisure travel, according to Pete Hillan, a partner at PR firm Singer Associates, which has clients in the hospitality industry.

WFH Research, which conducts surveys and research projects on work arrangements and hiring, released results last week showing remote work costs cities billions annually. According to data collected from June through November, the reduction in spending per person in New York City was $4,661, followed by $4,200 in Los Angeles and $4,051 in Washington, DC. The study outlined a dozen cities with annual spend reductions of over $2,000 per person.

Personal workdays fell the most in Washington, down 37% from pre-pandemic levels, followed by Atlanta at 34.9% and Phoenix at 34.1%. The information, financial, and professional and business services sectors are leading the way in working from home.

According to WFH Research co-founder Jose Maria Barrero, 28.2% of employees are hybrid—working some days in the office and some days remotely—compared to 12.7% who work entirely remotely. Though 59.1% of workers are on-site full-time, hospitality businesses that cater to office workers are still struggling to make ends meet, Barrero said. WFH Research found that before the pandemic, only 5% of paid work hours were done remotely.

Andrew Rigie, executive director of the New York City Hospitality Alliance, said people in business districts are more likely to spend more on breakfast or lunch or go out for after-work happy hour than at restaurants and bars in their own neighborhoods when working remotely.

However, the demand for corporate dinners and catered meals has not disappeared in many cases.

“We’ve found that there is significant demand from the business community, both for lunch and for the really fun happy hour later, in many ways at higher levels than before the pandemic,” said Steve Simon, Partners with Atlanta-based Fifth Group restaurants.

From the inner cities to the suburbs

This month, Manhattan’s only Ruth’s Chris Steakhouse announced it would be closing in April, and numerous midtown Manhattan restaurants, including the upscale Thai-inspired Random Access, have closed.

“Even if you’re busy on Wednesdays and Thursdays, your Mondays and Fridays can be really slow,” Rigie said. “If someone walks by a restaurant on a Thursday around lunch or dinner, they might say, ‘Wow, the restaurant is full, they’re so busy,’ but that’s not every day.”

The Bureau of Labor Statistics found in a study that an increase in remote work leads to a reduction in foot traffic in urban centers. A 10% drop in foot traffic in a census tract results in a 1.7% drop in employment in catering and accommodation, and a 1.6% drop in employment in wholesale and retail.

Areas with positive traffic growth saw employment gains in the same sectors.

“Particularly because the census areas where foot traffic has increased are more in the suburbs and moving away from the dense urban parts, it means that restaurant, bar and retail employment appears to be better in those areas suburban, less dense census areas,” said Michael Dalton, a bureau research economist who led the study published in August.

WFH Research’s Barrero said significant spending has been shifted to locations outside of inner cities, hurting city centers.

“To the extent that this shifts from New York City to adjacent counties within the metropolitan area, it means a lost sales tax for the city,” he said. “That goes hand in hand with a loss of passenger revenue and so on.”

Over the past six months, Barrero said, data has shown a stable number of days worked from home for the overall economy at just under 30%. There was a drop in remote work in January from 29% to about 27%, though he predicts the level of remote work will not fall below 25% in the near future.

“The bad news for these restaurant owners and whatnot is that I don’t think we’re going back to normal, and we’re probably pretty close to the new normal,” Barrero said.

resilience of the restaurant

Rigie of the New York City Hospitality Alliance said full-service restaurants could have more consistent business over the long term than fast-casual, limited-service restaurants that are more office-focused because of tourists and people going to shows crowds. However, full-service restaurants, which have higher overheads, will continue to struggle with staffing shortages, he said.

“Once the staff can see why I’m at this restaurant, when many nights aren’t as busy and I don’t make as much money, they might go to a restaurant in another neighborhood that’s busier earlier in the week” , he said .

Emily Williams Knight, CEO of the Texas Restaurant Association, said downtown Texas restaurants are seeing two different types of worker winbacks. She said Houston reported office space was 60% occupied, with a 30% vacancy rate, while Austin led the nation in returning to in-person work.

On a recent trip to downtown Houston, Williams Knight said she had “never seen empty streets like I’ve seen in the middle of the week, in the middle of the day.” She added that the return of conventions and business trips is particularly slow.

Houston and Dallas, which have an average commute time of nearly half an hour, have experienced small weekday crowds for lunch and happy hour in recent months. Combined with four decades of high inflation and labor costs that have risen more than 20% in the last two years, some restaurants have had to close or relocate, she said.

“If you had five, six, seven restaurants within blocks of each other and you could choose, you would try to go into town and eat at your favorite restaurant,” Williams Knight said. “Now that lack of choice is also keeping people at home, and all that dovetailing with that spending isn’t happening.”

Nick Livanos, owner of Livanos Restaurant Group, has two restaurants in Manhattan and two in Westchester. While Westchester restaurants offer more consistent lunch and dinner menus, Midtown’s Oceana is “extremely busy” on Tuesdays, Wednesdays, and Thursdays, but is much weaker on Mondays and Fridays.

Molyvos, the group’s upscale Greek restaurant, moved from Midtown to a smaller space in more residential Hell’s Kitchen in November. He said the new location has attracted longtime residents who are more loyal, like the Westchester crowd.

Rigie said inner cities need to focus on targeting not only office workers but also tourists and residents of nearby neighborhoods, while also having to change working hours, cut costs and build relationships with local businesses while remote work continues.

And despite discussions about converting many low-occupancy office buildings into residential units, restaurants may not benefit for years.

A handful of independent, single-unit restaurants in Houston and Dallas are moving to the suburbs.

Tracy Vaught, who owns five Houston-area restaurants, said business from downtown office workers isn’t picking up again until later in the week. Four of their restaurants are now closed on Mondays, and another is closed for lunch on Tuesdays and Wednesdays. She expects business to pick up at all locations as spring approaches.

“Suburb restaurants suffer from the same problems as downtown restaurants or in office parks, and that means not everyone is going back to work,” Vaught said.

Nikki Haley is moderated by Wall Avenue execs

Nikki Haley, a Republican who entered the 2024 presidential race this month, will attend a fundraiser for her campaign hosted by Wall Street executives in New York on Tuesday, according to an invitation first verified by CNBC.

The fundraiser hosts include Joseph Konzelmann, partner at private equity giant TPG; Gautam Chawla, deputy chairman of financial giant Barclays; and Evan Baehr, who is invited to head a venture capital firm headquartered in Austin, Texas. Tickets for the event range from $3,300 to $6,600.

The Federal Electoral Commission recently set new maximum contribution limits that donors can give to campaigns. You can contribute up to $3,300 in both the primary and general elections, or $6,600 that can be split between the two terms.

Tuesday’s fundraiser for Haley’s campaign marks one of her first trips to New York as a presidential candidate. The former South Carolina governor is looking to raise financial support when she faces former President Donald Trump and several other potential high-profile rivals in the 2024 GOP primary.

Morning Consult’s primary GOP tracker shows Haley receiving 6% support from prospective Republican voters. Former President Donald Trump has support from about 50% of GOP primary voters, according to Morning Consult.

Haley was the Trump administration’s ambassador to the United Nations.

Haley’s campaign will release her full fundraising data at the end of the first quarter, providing a glimpse of who supported her presidential bid early on. However, according to data from the non-partisan OpenSecrets, she is no stranger to support from the financial industry.

Their PAC, Stand for America, has received input from Paul Singer, founder of hedge fund Elliott Management, and James Haskel, a senior portfolio strategist at major investment firm Bridgewater Associates.

Finance executives have played a key role in fundraising for bipartisan political campaigns for well over a decade. Securities and investment industry professionals contributed more than $74 million to President Joe Biden’s successful 2020 campaign.

New York itself is a lucrative hunting ground for candidates looking to raise campaign funds. Over $610 million in campaign contributions came from the Empire State during the 2022 election cycle — over 71% of that went to Democrats and over 23% to Republicans, according to OpenSecrets.

The invitation to the Haley fundraiser said the gathering will be held in Tribeca, a small neighborhood in Manhattan about a mile from Wall Street that has historically been considered one of the most expensive ZIP codes in New York City. It did not include the exact location of the fundraiser.

When contacted by CNBC and asked why he was a co-host and how the event was organized, Chawla did not deny that he was a co-host. He said on the phone, “No, I won’t be speaking to you, but thanks for calling.”

A TPG representative declined to comment. A Baehr representative did not respond to a request for comment.

A spokeswoman for Haley’s campaign did not respond to a request for comment on further details about the former South Carolina governor’s trip to New York.

Konzelmann has previously endorsed Haley. According to a Federal Election Commission filing, he donated $5,000 to their PAC, Stand for America, last year.

Baehr has not donated to Haley’s PAC. He previously contributed to the campaigns of GOP congressional candidates such as Senator JD Vance, R-Ohio.

Chawla has only made three political campaign donations, according to OpenSecrets, and they all went to Democrats. He gave former New York City mayoral candidate Ray McGuire $2,500 and $250 to former Rhode Island Gov. Gina Raimondo’s campaign before she became Biden’s trade secretary.

CORRECTION: This article was updated to reflect that Gina Raimondo was the former governor of Rhode Island, not Delaware.

Moderna (MRNA) This autumn Outcomes 2022

Modern on Thursday missed fourth-quarter earnings expectations as costs rose from excess manufacturing capacity and lower demand for its Covid-19 vaccine, the company’s only product on the market.

Moderna reported quarterly earnings of $3.61 per share, down 68% from the same period in 2021 when it posted $11.29 per share. The number fell short of the $4.68 per share Wall Street had been expecting.

The Boston-based biotech generated sales of $5.1 billion in the fourth quarter of 2022, in line with analysts’ expectations but down 30% from the same period in 2021.

Shares of Moderna fell as much as 4% in Thursday morning trading.

Moderna has signed deals for $5 billion worth of Covid vaccine supplies for 2023. The company expects additional sales in the US, Europe and Japan this year, but demand for the vaccines is falling as the pandemic subsides and vaccination is shifted to an annual schedule rather than repeat increases.

The US government also plans to stop buying shots for the public as early as this summer and move sourcing and distribution to the private market. Moderna estimates the U.S. market size at 100 million doses in fall 2023, said Arpa Garay, the company’s chief commercial officer.

Garay would not make any predictions about Moderna’s share of the US market in the fall of 2023. She said the company is in talks with customers about fall contracts.

Here’s how the company has performed versus Wall Street expectations, based on average analyst estimates compiled by Refinitiv:

  • Adjusted result: $3.61 per share versus $4.68 expected
  • Revenue: $5.1 billion vs. $5 billion expected

Moderna sold $18.4 billion worth of vaccines in 2022, up 4% year over year and the company’s all-time high for sales during the pandemic. The company reported net income of $8.4 billion in 2022, down 31% from 2021.

The company said its costs rose 25% in the fourth quarter. Those expenses included a $297 million write-off for vaccines that have passed their shelf life, $376 million for unused manufacturing capacity, and a $400 million license fee to the National Institute of Allergy and Infectious Diseases.

Though the Covid syringe remains Moderna’s only product on the market, the company plans to seek approval from the Food and Drug Administration for its vaccine, which protects older adults from respiratory syncytial virus, in the first half of this year. after reporting positive data from a clinical trial. Moderna expects FDA approval in late 2023 or early 2024.

Garay said Moderna will use the infrastructure already in place for Covid to bring the RSV vaccine to market. She declined to provide details on how much Moderna will charge for the RSV vaccine, but said the company will ensure patients have access to the vaccine regardless of their ability to pay.

The company has another potential commercial product in the works. Last week, Moderna said its flu vaccine candidate met the immune response target against influenza A, the most common type, in its study but failed against influenza B. Independent data monitors will review initial efficacy results for the vaccine in the first quarter of this year, the company said.

“If we see efficacy, that’s the gold standard for regulatory submissions and full approval,” said Dr. Stephen Hoge, President and Research Director of Moderna, on Thursday. “If we are not yet at that threshold, we look forward to subsequent interim analyzes in this study.”

The FDA has also identified Moderna and Merck’s personalized cancer vaccine as a breakthrough therapy that could accelerate development and regulatory review of the vaccine.

Latto Talks About ‘Uplifting’ Different Feminine Rappers: ‘I am A Lady For Women’

During a recent meeting with Billboard, Latto reflected on her rise to the top and how she strives to help other aspiring female rappers.

Latto Reflects on the Women Who Supported Her: ‘Real Recognize Real’

Raised in Atlanta, the artist began reflecting on her musical beginnings as a teenager. She eventually dropped her 2020 breakout hit “B*tch From Da Souf.”

As she began to garner widespread attention, Latto notes that she received heaps of love and support from notable acts such as Trina, City Girls, Lizzo, SZA, Queen Latifah and Remy Ma.

Referring to the support she has received from her contemporaries, Latto coolly remarked, “Real recognizes Real.” IKTR!

“I get a lot of love,” she says with an exuberant smile. “Real recognizes real.”

pic.twitter.com/PaPVOCfqGd

— BIG LACT 🍀🎰🍒 (@Latto) February 4, 2023

The rapper says she’s a “girl’s girl” who wants others to be successful

While we’re on the subject, Latto also notes that — because she’s received so much love from other rappers — she “wants to capitalize [her] Power to uplift others.” After all, she is “a girl girl.”

“My #1 thing was being a girl. I use my power to uplift others on my way up.”

In fact, she notes that she doesn’t calculate “up and coming female rappers.”[s]’ for features as she selflessly wants to offer the same support she has received.

“If you see Latto doing a feature with an aspiring rapper, I don’t charge them anything. The label has to cover the glam, but I don’t benefit from that.”

However, Latto admits her journey hasn’t been entirely happy, as she’s no stranger to public feuds, which she describes as “disappointing”.

RELATED: Nicki Minaj and Latto trade insults after Nicki mentions ‘Big Energy’ in Grammys review

Despite this, Latto is focused on persevering and overcoming any difficulties that might arise during her career.

“It’s difficult to navigate through situations like this because there’s a disconnect. I’ll consider myself someone’s fan and they’ll see [me] in a completely different light. It’s disappointing. You just have to take it up to your chin and keep pushing.”

Instead of focusing on the negative, Latto is willing to explore and leverage new content. As the new track “Lottery” proves. What’s more, she’s ready to continue enjoying her role in creating “the new wave of rap.” Although she feels “honoured to be a part of it”.

“The content I’m about to release is a whole new leaf. I really love seeing the new wave of female rap and I’m honored to be a part of it.”

What do you think of Latto’s recent comment, and which rising female rap stars would you like to pair her with in the future?

Cinemas evolve, do not die

Girl is watching a comedy movie in the cinema with her friend.

Rgstudio | E+ | Getty Images

LOS ANGELES – Movies are still big. It’s the multiplexes that are getting smaller.

Since 2019, the number of total screens in the US has fallen by around 3,000 to just under 40,000.

This consolidation was a direct result of the Covid pandemic, which temporarily closed cinemas and sparked a surge in streaming subscriptions. A number of regional chains have closed for good, while others have had to reassess their financial footing. For many, that meant closing sites or selling leases.

“Think of the retail industry out there in general, it’s repositioning, you don’t have that many stores of the same brand in the market,” said Rolando Rodriguez, chairman of the National Association of Theater Owners. “Consumers are a lot more selective and I think you’re going to stop seeing those 30 plexes for economic reasons.”

Rodriguez said most newly built locations will have between 12 and 16 screens, and those with larger, pre-existing floor plans will seek to reallocate some space for additional moviegoer activities such as arcades, bowling alleys or bars.

Theaters have been forced to innovate even as Hollywood production returns to normal and studios have more films available for release than they could in the earlier stages of the pandemic.

As space contracts are finalized, cinema operators are investing in the basics, improving sound, picture quality and seating, as well as strengthening food and beverage offerings, events and alternative programming. The aim is to improve the basic experience for cinema-goers regardless of the type of ticket purchased.

“We’ll do better as people get used to seeing it,” said Larry Etter, senior vice president of family-owned regional chain Malco Theaters. “And I think that will happen. I think we’re going to recreate the usual effect of going to the movies on Friday night or Saturday night or whatever.”

The premium push

The industry is already seeing improvements in ticket sales. According to data from Comscore, the box office topped $958.5 million in ticket sales in 2023 through Monday, up nearly 50% year over year and down just 25% from 2019.

This is a significant improvement from a meager $98.7 million at the box office over the same period in 2021.

Foot traffic has also improved but remains below pre-pandemic levels. In the two decades leading up to the pandemic, the industry sold an average of 1.1 billion tickets a year, according to data from EntTelligence. Even when Covid restrictions were lifted in 2022, just over half that number of tickets were sold for the year. And ticket sales should increase in 2023 as studios release more films.

While cinema operators are happy about the increase in studio production, they no longer take the audience for granted.

To this end, operators have started upgrading projectors. In recent years, cinema operators have removed traditional digital projectors and installed laser units, citing cost savings and better image quality for moviegoers over time.

“It’s a bit pricey, but it will produce a better product on screen,” said Malco’s Etter. “The more light you have, the clearer everything is and the better it is to see. And it will be much more economical. It’s sustainable because you use about 60% of what you used to use.”

Etter explained that traditional digital lightbulbs need to be replaced after around 2,000 hours and produce so much heat that theaters have to pay more to air-condition the projector rooms. And laser components have a lifespan of 20,000 hours, so they can work for years without replacement.

Many theater operators told CNBC they are planning similar sound system upgrades and said they have partnered with companies like Dolby to bring quality speakers to their auditoriums.

“We’ve invested in Dolby Atmos, we’ve invested in new screens, we’ve invested in laser projection,” said Rich Daughtridge, President and CEO of Warehouse Cinemas. “For me, that’s the baseline. I think you have to create the best audio and visual experience you can create to motivate people to spend money to go to the cinema.”

General atmosphere during the private IMAX screening of the film: ‘First Man’ at IMAX AMC Theater on October 10, 2018 in New York City.

Lars Niki | Getty Images Entertainment | Getty Images

Across the industry, theater chains large and small are replacing outdated stadium seats with lounge chairs to improve the overall cinema experience.

“[We are] We really look at our theaters and make sure they’re all amazing,” said Shelli Taylor, CEO of Alamo Drafthouse. “So if they don’t have loungers, we go in and stock up. We’re doing a face lift where needed and just really freshening up and making sure we continue to provide the premium experience that people love and have come to expect from the Alamo.”

These improvements are part of a broader trend that began before the pandemic. Consumers are increasingly opting for premium cinema experiences for blockbuster feature films, choosing to spend more money to see films on larger screens or in specialized cinemas.

In 2022, 15% of all domestic tickets sold went to premium shows, with the average ticket costing $15.92, according to EntTelligence data. A standard ticket averages $11.29.

So far in 2023, that premium ticket average is higher – $17.33 each – because so many moviegoers have seen it Disney’s Avatar: The Way of Water in premium formats and 3D.

Event cinema, niche programming

Big blockbusters have always been a driving force in cinema ticket sales. Before the pandemic, movie theater owners relied heavily on studio advertising—trailers, TV spots, and posters—to promote content and attract moviegoers to theaters. Now they’re putting more into that mix.

Loyalty programs, direct marketing, and special events are some of the recent tactics operators are using to attract viewers. AMC launched its first-ever advertising campaign in 2021, starring Nicole Kidman and the slogan “We Make Movies Better.” The company invested around 25 million US dollars in the campaign.

Budget-conscious smaller chains need to be a little more creative.

“I’ve had many discussions with distributors about better and more efficient ways to market their films,” said Warehouse’s Daughtridge. “Often that’s data marketing and paid social, better trailer placements and [putting] Tickets on sale at the right time.”

“I think there’s a lot of low-hanging fruit,” he said of email lists, loyalty programs, and social media for personalized marketing.

The Warehouse, which will soon be opening its third location, has also run promotions ranging from offering margaritas with movie tickets to special “father-daughter” date night screenings. In the midst of the pandemic, Warehouse Cinemas capitalized on the release of Solstice Studio’s Unhinged by hosting a car crash event during the film’s fifth week in cinemas.

More recently, the chain ran Pajamas and Popcorn, a promotion where customers who went to the movies in their pajamas received free popcorn. During this promotion, the company screened an Indiana Jones film and the classic animated dinosaur film The Land Before Time. Tickets were $5 each.

“The Land Before Time” screenings sold 1,400 tickets, Daughtridge said.

“It was one of those events that just happened,” he said. “We didn’t expect it to do so much business.”

For big chains like AMCshelf and Cinemamarkthere are alternative programming in the form of live events, with cinemas setting up streams for concerts, sports and even Dungeons & Dragons campaigns.

Mid-size chains like Alamo Drafthouse even delve into the quirky. When the Oscar-winning Everything Everywhere All at Once hit theaters, the theater chain gave out hot dogs to ticket buyers who went to their “Feast” event to celebrate the film’s famous hot dog finger scene.

Still from A24’s Everything Everywhere All at Once.

A24

The company also worked with the Lincoln Zoo prior to the opening of its new location in Chicago’s Wrigleyville neighborhood to host an outdoor screening of The Lion King in the zoo’s lion den.

Alamo isn’t the only chain innovating when it comes to food and drink. Concessions have long been a staple at cinema, but in recent years theater owners have expanded on the traditional popcorn and soda fare.

Cinepolis, which operates more than two dozen movie theaters in eight states, is a luxury dine-in theater chain that offers a wide variety of food and drink options, from chicken wings to lobster tacos. Cinepolis is hosting “Movie and a Meal,” a special dinner themed around a specific new movie release.

“For us, food is critical to the local experience,” said Luis Olloqui, CEO of Cinepolis, noting that more and more people have big HD TVs in their homes coupled with the ability to order from world-class restaurants.

That trend is unlikely to slow, and industry insiders are optimistic about the future of the cinema business.

“I think unfortunately we’ve had some very bad PR aspects as Covid has progressed,” said Rodriguez of the National Association of Theater Owners. “And now we need to rebuild that muscle in consumers and remind them, ‘Hey, you know, that’s behind us. Theaters are fine.’”

FDA says Guillain-Barre syndrome is a possible danger for a Pfizer RSV vaccine

This 1981 photo provided by the Centers for Disease Control and Prevention (CDC) shows an electron micrograph of respiratory syncytial virus, also known as RSV.

CDC via AP

The Food and Drug Administration sees a possible risk of Guillain-Barre syndrome Pfizer‘s RSV vaccine for older adults and has asked the company to conduct a safety study if the vaccine is approved this spring, according to agency briefing papers released on Friday.

According to the FDA document, two people in their 60s who received Pfizer’s vaccine were diagnosed with Guillain-Barre syndrome, out of about 20,000 vaccine recipients in the Phase 3 study. There were no cases in the study’s placebo group, the people who did not receive the injection.

Guillain-Barré Syndrome, or inflammatory neuropathy, is a rare condition in which the body’s immune system mistakenly attacks nerves. Symptoms range from brief weakness to paralysis, according to the National Institutes of Health. Most people recover even from severe cases.

Pfizer said in its briefing document that the cases have other possible explanations. However, it said it would conduct a safety study to further evaluate Guillain-Barré syndrome after a possible approval. The company said it did not identify any safety concerns during the study and that the vaccine was well tolerated.

There was also a possible case of Guillain-Barré Syndrome in GSK‘s RSV vaccine trials, but the company said there was insufficient evidence to confirm a diagnosis. According to the FDA, GSK has listed Guillain-Barre as an important potential risk in its safety monitoring plan. The agency said it will review the plan and make recommendations as necessary.

The FDA released the briefing documents ahead of its advisory committee meetings next week. Advisors will vote on Tuesday whether Pfizer’s efficacy and safety data support FDA approval. They will also vote on GSK’s RSV vaccine for older adults on Wednesday.

There is no approved RSV vaccine. The virus causes between 6,000 and 10,000 deaths among seniors annually, although mortality varies from season to season.

According to an FDA review of the companies’ data, Pfizer’s vaccine was 85% effective in preventing lower respiratory tract disease and GSK’s vaccine was 83% effective.

The Guillain Barre Falls

In Pfizer’s study, a 66-year-old man in the US with a history of high blood pressure developed Guillain-Barre symptoms seven days after vaccination. The man had a heart attack before symptoms began, was hospitalized and underwent angioplasty. The FDA does not see the heart attack as related to the RSV vaccine.

Eight days after the vaccination, the man developed back pain and, on the 14th day, weakness in his lower extremities. He was hospitalized again after a fall and was subsequently diagnosed with Guillain-Barre Syndrome. His symptoms began to improve after treatment and disappeared six months after onset, according to the FDA.

In a second case, a 66-year-old woman in Japan with a history of type 2 diabetes developed severe Miller-Fischer syndrome, a variant of Guillain-Barre. She suffered from fatigue nine days after the vaccination, a sore throat the next day and poor muscle control on the tenth day. She was hospitalized 19 days after the vaccination, but her symptoms completely disappeared in three months.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The FDA said it agrees with investigators that the cases may be related to Pfizer’s vaccines. But Pfizer said in its briefing document that there are other possible explanations. The company pointed out the man’s heart attack and said the woman had symptoms of an upper respiratory infection.

But the FDA said that given the incidence of Guillain-Barre syndrome in the general population is about 3 cases per 100,000 people annually, Pfizer should consider the incidents as an important potential risk in its safety surveillance.

“Given the temporal association and biological plausibility, the FDA concurs with the investigators’ assessment that these events may be related to the study vaccine,” the agency said.

In the case of GSK, a 78-year-old woman in Japan developed lower-limb weakness nine days after receiving the first dose of the RSV vaccine, according to an FDA briefing document. She took part in an open-label study without a placebo arm for comparison.

The woman had difficulty walking the following day and developed weakness in her upper limbs and respiratory muscles over the next three days. She was hospitalized and treated for Guillain-Barré Syndrome. The FDA and study investigator believe the case is vaccine-related.

But GSK said in its briefing document that a Guillain-Barre diagnosis was not confirmed due to a lack of test results and because there was no information on whether alternative causes had been investigated. The patient’s case was considered settled after six months, the company said.

CDC consultants discuss risks and benefits

The Centers for Disease Control and Prevention’s committee of independent immunization consultants considered the three cases of Guillain-Barré syndrome during a public meeting Thursday. dr Michael Melgar, a CDC official, told the committee it was difficult to determine whether the cases represent an actual safety issue related to the shooting or whether they were random events.

“Due to the small number of events, measures of relative and absolute risk were not calculated,” Melgar told committee members.

However, a working group of doctors and health officials that reviewed the available data agreed that safety monitoring will be critical if the vaccines are approved by the FDA, Melgar said.

A majority of the working group believed the potential benefits of the vaccines would outweigh any possible risks for people aged 65 and older, Melgar said. A minority considered the balance of benefits and risks uncertain, partly because of the Guillain-Barre cases.

Although Pfizer and GSK have asked the FDA to approve their respective vaccines for people age 60 and older, the CDC working group generally endorsed a recommendation for seniors age 65 and older. The CDC advisory committee did not vote on any recommendations for the RSV vaccines this week.

dr Sarah Long, a member of the working group, said the cases had her concerned because the incidence of Guillain-Barre syndrome increases with age, meaning seniors could be at higher risk if at some point a link with the disease is found vaccine is found.

dr Grace Lee, chair of the CDC advisory committee, said more data is needed because respiratory viral diseases also cause Guillain-Barré syndrome. It is possible that the vaccines could prevent further cases of Guillain-Barré syndrome by protecting against RSV disease.

“They might prevent more and we don’t know exactly what the rate is, but I just think that balance will be really helpful, at least for me, to understand how to think through the risk-benefit balance.” , said Lee, associate chief medical officer at Stanford Children’s Health, “Then I can understand whether 60-year-old or 65-year-old makes sense.”

Join CNBC’s Healthy Returns on March 29, where we’re hosting a virtual gathering of healthcare CEOs, scientists, investors and innovators to reflect on the advances made today to reinvent the future of medicine. We also have an exclusive look at the best investment opportunities in biopharma, healthcare technology and managed care. Learn more and register today: http://bit.ly/3DUNbRo

It positive looks like Trump’s legal professional thinks he’ll be indicted

Trump’s attorney Christina Bobb argued that Trump should not be criminally charged over the comments made by the special chairman of the Georgia grand jury. Essentially, Bobb was attempting to ward off criminal charges.

Video:

Trump attorney Christina Bobb says Trump should not be indicted in GA because the grand juror interviews “spoiled the jury pool for a future trial.” “There should be no indictment, the jury pool has been corrupted.” pic.twitter.com/s21SblXykv

— Ron Filipkowski 🇺🇦 (@RonFilipkowski) February 25, 2023

Bobb said that the previous person “completely spoiled the jury pool, because now you have a whole jury pool of people who believe there’s a crime that President Trump or his allies committed, but nobody knows what.” It is. So here they are trying to get ahead of the game and try to pollute the jury, try to make the public believe there is a crime here without giving them a chance to defend themselves… It should mean there isn’t charges. The jury pool has been tainted. Every defendant, whether President Trump or his allies, all have had their constitutional rights violated by this media tour by the prosecutor allowing this insanity.”

For more stories like this, subscribe to our newsletter:

Everything Trump’s attorney said above was wrong. The judge overseeing the special grand jury said the foreman’s comments did not break the rules. The special grand jury has nothing to do with indictments. They are an investigative agency that makes recommendations.

DA Fani Willis will convene a second grand jury to vote on possible charges. The special grand jury foreman never named Trump or any of his allies, so a possible future jury pool could not be spoiled.

There is no reason for Trump’s attorney to make that argument unless they believe he will be indicted.

If the phone calls were as perfect as Trump claims, there would be no worries of indictment. It’s not the prosecution trying to pre-empt the case, it’s Trump.

By launching a pre-emptive defense, Trump and his legal team are admitting they believe he will be charged.

Jason is the managing editor. He is also a White House press pool and congressional correspondent for PoliticusUSA. Jason has a bachelor’s degree in political science. His thesis focused on public policy with a specialization in social reform movements.

Awards and professional memberships

Member of the Society of Professional Journalists and the American Political Science Association